کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2905609 | 1173431 | 2006 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Long-term Survivorship in Lung Cancer
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
QOLCES-DSF-36SPLCNHISQuality of life - کیفیت زندگیSurvivors - بازماندگانSCLC - بگذارندNSCLC - سرطان ریوی غیر سلول کوچکSmall cell lung cancer - سرطان سلول کوچک ریهNon-small cell lung cancer - سرطان غیر سلول کوچک ریهSEER - سرندCenter for Epidemiologic Studies Depression Scale - مرکز مقیاس افسردگی مطالعات اپیدمیولوژیکMedical Outcomes Study 36-Item Short Form - مقالات پزشکی نتایج مطالعه فرم 36 درصدی موردLung neoplasms - نئوپلاسم های ریهSurveillance, Epidemiology, and End Results - نظارت، اپیدمیولوژی و پایان دادن به نتایجNational Health Interview Survey - نظرسنجی مصاحبه بهداشت ملی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
While outcome research in lung cancer has focused mainly on short-term survival and quality of life (QoL), information on long-term (ie, > 5 years postdiagnosis) lung cancer survivorship remains limited. This review addresses the epidemiologic significance of long-term lung cancer (LTLC) survivors, summarizes the current knowledge on their health and QoL, and suggests areas for further research in LTLC survivorship. Based on a small body of literature, lung cancer survivors do not experience the same quantity and QoL as their age-matched peers or as survivors of other cancers. Survival among 5-year survivors of lung cancer relative to the general US population with the same demographic characteristics is approximately 60%, and lung cancer survivors score lowest in health utility among long-term survivors of other cancers. Approximately one-quarter of long-term lung cancer (LTLC) survivors were significantly restricted in physical ability or reported significant depressive symptoms. There is a need to identify and intervene with subgroups of survivors who are at an elevated risk of premature death and diminished QoL. Lung cancer-specific survival alone does not reflect the overall illness burden in LTLC survivors. Patient care in lung cancer survivors should be continuous and comprehensive in considering multiple causes of health deterioration. Multidisciplinary research in epidemiologic, clinical, and basic science approaches is warranted to further our knowledge base for optimal long-term management and to develop the necessary intervention strategies among LTLC survivors.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Chest - Volume 129, Issue 4, April 2006, Pages 1088-1097
Journal: Chest - Volume 129, Issue 4, April 2006, Pages 1088-1097
نویسندگان
Sugimura MD, Yang MD, PhD,